Association between methylation of SHP-1 isoform I and SSTR2A promoter regions with breast and prostate carcinoma development

Cancer Invest. 2015 Mar;33(3):61-9. doi: 10.3109/07357907.2014.1001892. Epub 2015 Jan 30.

Abstract

Methylation pattern is presented here for first time as a potential molecular marker of changes on SSTR2A and SHP-1(I) gene promoter related to breast and prostate carcinoma. Our results have shown low concordances with SSTR2A and methylated state in prostate cancer and moderate relationship with unmethylated CpG-27 in breast cancer. We found significant concordances for both cancers and SHP-1(I) unmethylation, and increased HER2 expression and SSTR2A methylation in breast cancer. Moreover, we found a correlation between methylation patterns of two genes in normal breast tissue. These data might assist to select subgroups of patients for the administration of alternative therapies.

Keywords: Breast cancer; Concordance; Methylation pattern; Prostate cancer; SHP-1(I); SSTR2A.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biomarkers, Tumor / genetics*
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology
  • DNA Methylation*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Promoter Regions, Genetic
  • Prostatic Neoplasms / genetics*
  • Prostatic Neoplasms / metabolism
  • Prostatic Neoplasms / pathology
  • Protein Isoforms
  • Protein Tyrosine Phosphatase, Non-Receptor Type 6 / genetics*
  • Receptors, Somatostatin / genetics*
  • Receptors, Somatostatin / metabolism

Substances

  • Biomarkers, Tumor
  • Protein Isoforms
  • Receptors, Somatostatin
  • somatostatin receptor 2
  • PTPN6 protein, human
  • Protein Tyrosine Phosphatase, Non-Receptor Type 6